← All stocks

Akebia Therapeutics, Inc.

AKBA Net buying

CIK 0001517022 #3754 in the set updated 19 Sep 2026

Bought (12 mo)

$86.59K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$962.96K

$962.96K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 16 sales

Net

−$876.37K

+$86.59K against sales at will

By person

13 insiders · 18 transactions

4.7×

John P. Butler holds only 4.7 times base salary in stock. $4.13M of shares against $864.01K in salary for 2025.

Salary from the company's own proxy. The shares are what John P. Butler last reported holding, valued at $1.11, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Butler John P.

CEO and President

$86.59K (1)

$474.41K (4) scheduled

−$387.83K

3,718,564

1.34%

$4.13M

+68.1%

Grund Nicholas

Chief Commercial Officer

—

$117.91K (2) scheduled

−$117.91K

561,750

0.2027%

$623.54K

+85.2%

Ostrowski Erik

SVP, CFO, CBO & Treasurer

—

$110.76K (2) scheduled

−$110.76K

616,616

0.2225%

$684.44K

+76.2%

Rucci Carolyn M.

SVP, Chief Legal Officer

—

$96.98K (3) scheduled

−$96.98K

588,378

0.2123%

$653.10K

+25.7%

Burke Steven Keith

SVP, Chief Medical Officer

—

$94.04K (3) scheduled

−$94.04K

948,432

0.3423%

$1.05M

+40.5%

Malabre Richard C

SVP, Chief Accounting Officer

—

$68.84K (2) scheduled

−$68.84K

299,390

0.1080%

$332.32K

+31.1%

ADAMS ADRIAN

Director

—

236,200

0.0852%

$262.18K

+43.3%

ROGERS MICHAEL W

Director

—

197,429

0.0712%

$219.15K

+56.7%

Smith Cynthia

Director

—

196,633

0.0710%

$218.26K

+57.0%

Wolf Myles

Director

—

169,081

0.0610%

$187.68K

+73.1%

FRIESON RON

Director

—

165,200

0.0596%

$183.37K

+124.2%

GILMAN STEVEN C

Director

—

152,830

0.0552%

$169.64K

+30.5%

ZUMWALT LEANNE M

Director

—

145,100

0.0524%

$161.06K

+96.9%

Akebia Therapeutics, Inc.

By person

Individual transactions

What was left out